×

DNA Sequencing Market Size, Share, Trends, Growth Outlook

DNA Sequencing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product & Service (Consumables, Instruments, Services), By Technology (Sanger Sequencing, Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing), Third Generation Sequencing (Single-Molecule Real-Time Sequencing, Nanopore Sequencing), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others), By End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), Countries and Companies Report

  • Home
  • Healthcare
  • DNA Sequencing Market
  • |Published Month : February, 2024
  • |No. of Pages : 209

DNA Sequencing Market is estimated to increase at a growth rate of 22.3% CAGR over the forecast period from 2024 to 2032.


The DNA Sequencing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product & Service (Consumables, Instruments, Services), By Technology (Sanger Sequencing, Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing), Third Generation Sequencing (Single-Molecule Real-Time Sequencing, Nanopore Sequencing), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others), By End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others).
 

An Introduction to DNA Sequencing Market in 2024

The DNA Sequencing Market in 2024 is witnessing exponential growth, propelled by advancements in next-generation sequencing (NGS) technologies, declining sequencing costs, and the expanding applications of genomic sequencing in healthcare, research, and personalized medicine. DNA sequencing plays a pivotal role in decoding the genetic blueprint of organisms, unraveling disease mechanisms, and guiding precision diagnostics and treatment strategies. With continuous innovations in sequencing platforms, sequencing chemistry, and bioinformatics algorithms, the market offers high-throughput and cost-effective solutions for genome sequencing, transcriptome analysis, epigenetics profiling, and metagenomics research. Moreover, the integration of NGS with clinical decision support systems, electronic health records, and population genomics initiatives further accelerates the adoption of DNA sequencing in routine clinical practice, driving market growth and revolutionizing healthcare delivery and disease management.

DNA Sequencing Market Dynamics

DNA Sequencing Market Trend: Rise in Adoption of Next-Generation Sequencing (NGS) Technologies

The DNA sequencing market is witnessing a prominent trend towards the rise in adoption of next-generation sequencing (NGS) technologies. NGS platforms offer high-throughput sequencing capabilities, enabling rapid and cost-effective analysis of DNA samples for a wide range of applications, including genomics research, clinical diagnostics, and personalized medicine. With continuous advancements in sequencing technologies, increased automation, and decreasing sequencing costs, there is growing utilization of NGS across various sectors, driving innovation and market growth in the DNA sequencing segment.


DNA Sequencing Market Driver: Expanding Applications in Healthcare and Life Sciences

A significant driver propelling the DNA sequencing market is the expanding applications of sequencing technologies in healthcare and life sciences. DNA sequencing plays a crucial role in genomic analysis, disease diagnosis, drug discovery, and precision medicine, driving demand for sequencing platforms and services. From cancer genomics and infectious disease surveillance to prenatal screening and pharmacogenomics, the applications of DNA sequencing continue to expand, fueled by advancements in bioinformatics, data analysis, and genomic research. This expanding utility of sequencing technologies in diverse fields strengthens market demand and fosters innovation in DNA sequencing solutions.


DNA Sequencing Market Opportunity: Integration with Artificial Intelligence for Data Analysis

An opportunity within the DNA sequencing market lies in the integration of sequencing platforms with artificial intelligence (AI) for data analysis. The vast amount of sequencing data generated by NGS platforms requires sophisticated bioinformatics tools and computational algorithms for interpretation and analysis. By integrating AI-driven analytics into DNA sequencing workflows, companies can enhance data processing speed, accuracy, and interpretation, enabling researchers and clinicians to extract meaningful insights from genomic data more efficiently. This integration presents an opportunity to improve sequencing data analysis workflows, unlock new discoveries in genomics, and advance personalized medicine initiatives with AI-powered genomic insights.


DNA Sequencing Market Segmentation

By Product & Service
Consumables
Instruments
Services


By Technology

  • Sanger Sequencing
  • Next-Generation Sequencing

-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing

  • Third Generation Sequencing

-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow

  • Pre-sequencing
  • Sequencing
  • Data Analysis


By Application

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others


By End-user

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others


Geographical Analysis

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

DNA Sequencing Market Companies

  • Thermo Fisher Scientific Inc
  • Agilent Technology
  • Illumina Inc
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Macrogen Inc
  • PerkinElmer Genomics
  • PacBio
  • BGI
  • Bio-Rad Laboratories Inc
  • Myriad Genetics
  • PierianDx
  • Partek Incorporated
  • Eurofins Scientific

*List not exhaustive

 

Reasons to Buy the DNA Sequencing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the DNA Sequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the DNA Sequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 DNA Sequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global DNA Sequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 DNA Sequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 DNA Sequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 DNA Sequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 DNA Sequencing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of DNA Sequencing Market Industry
4.2 Key Market Trends in DNA Sequencing Market Industry
4.3 Potential Opportunities in DNA Sequencing Market Industry
4.4 Key Challenges in DNA Sequencing Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global DNA Sequencing Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global DNA Sequencing Market Outlook By Segments
7.1 DNA Sequencing Market Outlook by Segments
By Product & Service
Consumables
Instruments
Services

By Technology
Sanger Sequencing
Next-Generation Sequencing
-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing
Third Generation Sequencing
-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow
Pre-sequencing
Sequencing
Data Analysis

By Application
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

8 North America DNA Sequencing Market Analysis And Outlook To 2030
8.1 Introduction to North America DNA Sequencing Markets in 2024
8.2 North America DNA Sequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America DNA Sequencing Market size Outlook by Segments, 2021-2030
By Product & Service
Consumables
Instruments
Services

By Technology
Sanger Sequencing
Next-Generation Sequencing
-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing
Third Generation Sequencing
-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow
Pre-sequencing
Sequencing
Data Analysis

By Application
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

9 Europe DNA Sequencing Market Analysis And Outlook To 2030
9.1 Introduction to Europe DNA Sequencing Markets in 2024
9.2 Europe DNA Sequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe DNA Sequencing Market Size Outlook By Segments, 2021-2030
By Product & Service
Consumables
Instruments
Services

By Technology
Sanger Sequencing
Next-Generation Sequencing
-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing
Third Generation Sequencing
-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow
Pre-sequencing
Sequencing
Data Analysis

By Application
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

10 Asia Pacific DNA Sequencing Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific DNA Sequencing Markets in 2024
10.2 Asia Pacific DNA Sequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific DNA Sequencing Market size Outlook by Segments, 2021-2030
By Product & Service
Consumables
Instruments
Services

By Technology
Sanger Sequencing
Next-Generation Sequencing
-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing
Third Generation Sequencing
-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow
Pre-sequencing
Sequencing
Data Analysis

By Application
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

11 South America DNA Sequencing Market Analysis And Outlook To 2030
11.1 Introduction to South America DNA Sequencing Markets in 2024
11.2 South America DNA Sequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America DNA Sequencing Market size Outlook by Segments, 2021-2030
By Product & Service
Consumables
Instruments
Services

By Technology
Sanger Sequencing
Next-Generation Sequencing
-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing
Third Generation Sequencing
-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow
Pre-sequencing
Sequencing
Data Analysis

By Application
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

12 Middle East And Africa DNA Sequencing Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa DNA Sequencing Markets in 2024
12.2 Middle East and Africa DNA Sequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa DNA Sequencing Market size Outlook by Segments, 2021-2030
By Product & Service
Consumables
Instruments
Services

By Technology
Sanger Sequencing
Next-Generation Sequencing
-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing
Third Generation Sequencing
-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow
Pre-sequencing
Sequencing
Data Analysis

By Application
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others

By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Thermo Fisher Scientific Inc
Agilent Technology
Illumina Inc
QIAGEN
F. Hoffmann-La Roche Ltd
Macrogen Inc
PerkinElmer Genomics
PacBio
BGI
Bio-Rad Laboratories Inc
Myriad Genetics
PierianDx
Partek Incorporated
Eurofins Scientific

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

DNA Sequencing Market Segmentation

By Product & Service
Consumables
Instruments
Services


By Technology

  • Sanger Sequencing
  • Next-Generation Sequencing

-Whole Genome Sequencing (WGS)
-Whole Exome Sequencing (WES)
-Targeted Sequencing & Resequencing

  • Third Generation Sequencing

-Single-Molecule Real-Time Sequencing (SMRT)
-Nanopore Sequencing

By Workflow

  • Pre-sequencing
  • Sequencing
  • Data Analysis


By Application

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others


By End-user

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others


Geographical Analysis

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Frequently Asked Questions

Related Reports